Valuation: AcuCort AB

Market Cap 148M 15.23M 13.37M 12.44M 11.41M 21.45M 1.47B 21.78M 57.7M 721M 57.17M 55.93M 2.49B P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 121M 12.44M 10.93M 10.16M 9.33M 17.52M 1.2B 17.79M 47.15M 589M 46.71M 45.7M 2.04B EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day+4.30%
1 week-1.25%
Current month+3.62%
1 month+9.38%
3 months-20.65%
6 months-21.93%
Current year+5.00%
1 week 0.53
Extreme 0.53
0.65
1 month 0.53
Extreme 0.53
0.67
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.26
5 years 0.33
Extreme 0.327
4.98
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 2020-08-08
Corporate Officer/Principal 53 2025-10-13
Director TitleAgeSince
Director/Board Member 68 2017-02-07
Chairman 63 2017-12-31
Director/Board Member 79 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.30%-1.25%-6.94%-47.50% 14.49M
-1.33%-5.61%-24.10%-29.19% 15.25B
-2.62%-3.75%-29.83%-33.86% 7.07B
+0.63%-0.45%-22.57%-8.61% 5.86B
-1.00%+1.63%-9.10%-29.46% 3.94B
-0.16%+0.22%-30.68%-48.68% 3.16B
-1.55%-4.42%+7.67%-31.67% 3.14B
-3.98%-5.93%-42.91%-18.65% 2.93B
+1.68%+4.45%-14.82%+3.88% 2.57B
+2.56%-0.17%+99.46% - 2.5B
Average -0.15%-1.50%-7.38%-27.08% 4.64B
Weighted average by Cap. -0.98%-2.26%-15.83%-26.16%

Financials

2024 2025
Net sales 7.72M 796K 699K 650K 596K 1.12M 76.62M 1.14M 3.01M 37.67M 2.99M 2.92M 130M 6.68M 689K 605K 563K 516K 970K 66.35M 985K 2.61M 32.62M 2.59M 2.53M 113M
Net income -17.4M -1.79M -1.58M -1.47M -1.34M -2.53M -173M -2.57M -6.8M -84.92M -6.73M -6.59M -294M -26.19M -2.7M -2.37M -2.21M -2.02M -3.8M -260M -3.86M -10.23M -128M -10.14M -9.92M -442M
Net Debt -2.77M -286K -251K -233K -214K -402K -27.52M -409K -1.08M -13.53M -1.07M -1.05M -46.78M -27.01M -2.78M -2.45M -2.27M -2.09M -3.92M -268M -3.98M -10.55M -132M -10.45M -10.23M -456M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
5
Date Price Change Volume
26-07-24 SEK 0.6300 +4.30% 303,208
26-07-23 SEK 0.6040 -4.73% 75,130
26-07-22 SEK 0.6340 +0.96% 21,941
26-07-21 SEK 0.6280 -0.32% 45,840
26-07-20 SEK 0.6300 -0.94% 969,105
  1. Stock Market
  2. Stocks
  3. ACUC Stock